Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European …
S Cesaro, P Ljungman, M Mikulska, HH Hirsch… - Leukemia, 2022 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …
Global and multi-national prevalence of fungal diseases—estimate precision
Fungal diseases kill more than 1.5 million and affect over a billion people. However, they are
still a neglected topic by public health authorities even though most deaths from fungal …
still a neglected topic by public health authorities even though most deaths from fungal …
Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Changes in the epidemiological landscape of invasive candidiasis
F Lamoth, SR Lockhart, EL Berkow… - Journal of …, 2018 - academic.oup.com
The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …
of the changes and the implications for current and future diagnosis and treatment. The …
[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
AJ Ullmann, JM Aguado, S Arikan-Akdagli… - Clinical Microbiology …, 2018 - Elsevier
Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …
European Confederation of Medical Mycology and the European Respiratory Society Joint …
[HTML][HTML] ESCMID guideline for the diagnosis and treatment of biofilm infections 2014
Biofilms cause chronic infections in tissues or by developing on the surfaces of medical
devices. Biofilm infections persist despite both antibiotic therapy and the innate and adaptive …
devices. Biofilm infections persist despite both antibiotic therapy and the innate and adaptive …
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
R Bellmann, P Smuszkiewicz - Infection, 2017 - Springer
Introduction Because of the high mortality of invasive fungal infections (IFIs), appropriate
exposure to antifungals appears to be crucial for therapeutic efficacy and safety. Materials …
exposure to antifungals appears to be crucial for therapeutic efficacy and safety. Materials …
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
HR Ashbee, RA Barnes, EM Johnson… - Journal of …, 2014 - academic.oup.com
The burden of human disease related to medically important fungal pathogens is
substantial. An improved understanding of antifungal pharmacology and antifungal …
substantial. An improved understanding of antifungal pharmacology and antifungal …
[HTML][HTML] How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing …
MC Arendrup, N Friberg, M Mares, G Kahlmeter… - Clinical Microbiology …, 2020 - Elsevier
Background EUCAST has revised the definition of the susceptibility category I from
'Intermediate'to 'Susceptible, Increased exposure'. This implies that I can be used where the …
'Intermediate'to 'Susceptible, Increased exposure'. This implies that I can be used where the …
[HTML][HTML] Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell …
J Styczynski, W van der Velden, CP Fox… - …, 2016 - ncbi.nlm.nih.gov
Epstein-Barr virus-related post-transplant lymphoproliferative disorders are recognized as a
significant cause of morbidity and mortality in patients undergoing hematopoietic stem cell …
significant cause of morbidity and mortality in patients undergoing hematopoietic stem cell …